CoChat

Candida albicans enhances iron uptake to maintain fluconazole resistance

Open access
Sharma, Rishabh, Nahar, Anubhav, Puri, Sumant · 2025 · Infection and Immunity

The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index; 16 of the 22 sources its claims cite were checked for support.

Abstract

A fluconazole-resistant Candida albicans strain shows enhanced intracellular iron accumulation, upregulated FRP1/FRE10/RBT5, increased ergosterol and ERG11/ERG9 expression, and deferasirox-fluconazole synergy.

Overview

CoChat Summary

TL;DR

Fluconazole-resistant (FR) *Candida albicans* accumulates more intracellular iron and upregulates iron-uptake genes, which supports iron-dependent increases in ergosterol biosynthesis and β-glucan exposure that help maintain fluconazole resistance. The FDA-approved iron chelator deferasirox (DFX) alone or with fluconazole kills FR lab and clinical strains, and low host iron reduces FR fungal burden during fluconazole treatment.

Key findings

  • The lab-generated FR strain had fluconazole MIC >125 µg/mL versus 0.48 µg/mL for parent CAI4, but was twofold more sensitive to DFX (MIC 4.66 µg/mL vs 9.34 µg/mL). A sublethal DFX dose (2.33 µg/mL) synergized with 125 µg/mL fluconazole to completely inhibit FR growth.
  • FR cells had significantly higher intracellular iron than CAI4 under both low and high iron (P < 0.05 and P < 0.0001, respectively), with upregulated expression of iron-uptake genes *FRP1*, *FRE10*, and *RBT5*, especially under high iron; the iron-utilization gene *BIO2* showed no difference.
  • FR cells showed higher membrane ergosterol and expression of *ERG11* and *ERG9* under both iron conditions, plus higher β-glucan levels under high iron and greater β-glucan exposure under both conditions. Efflux was higher in FR (4.46-fold under high iron, 3.62-fold under low iron) but was iron-independent.
  • In a murine oropharyngeal candidiasis model, fluconazole-treated mice with high iron had higher tongue fungal burden (log10 5.873) than low-iron mice (log10 5.454; P = 0.0107). DFX also synergized with fluconazole to kill FR clinical strains.

Methods

  • *Strains and culture*: CAI4 + URA was the parent; the FR strain was generated by passaging CAI4 on fluconazole (128 µg/mL then 256 µg/mL) and maintained at 128 µg/mL. Deidentified clinical FR strains were received from Dr. Damian Krysan. Low-iron medium was YNB + 2% glucose; high-iron medium added 100 µM FeCl3·6H2O.
  • *Assays*: fluconazole/DFX MIC and CFU viability; intracellular iron by colorimetric assay; gene expression by real-time PCR normalized to 18S rRNA; ergosterol quantification; β-glucan level/exposure by aniline blue and anti-β-1,3-glucan antibody; efflux by rhodamine 6G.
  • *Mouse model*: 4- to 6-week-old female C57BL/6 mice were immunosuppressed with cortisone acetate, given iron-dextran (high iron) or DFX in drinking water (low iron), infected sublingually with FR, treated with fluconazole 1 mg/kg/day, and tongue CFU/g measured on day 5 (n = 10). Statistics used Mann-Whitney or one-way ANOVA, P < 0.05.

Limitations

  • The paper does not include a dedicated limitations section. The authors state that the mechanism by which FR strains evolve sensitivity to iron chelation “requires further investigation.”
  • Evident from the text: the main FR strain is lab-generated by passaging, so findings may not fully represent clinical FR isolates; clinical strains were tested only in vitro. Some experiments had limited replication (e.g., ergosterol and clinical-strain assays with two biological repeats; efflux shown as one representative experiment), and growth-rate data under high/low iron are reported as “data not shown.” The in vivo experiment used n = 10 mice per group.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1128/iai.00002-25

Cites

39 of 39 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Fig 1 FR strain is more sensitive to iron chelation that can synergize with fluconazole-treatment to overcome resistance. (A) In vitro susceptibility study to fluconazole (0.24–125 µg/mL) and DFX (0.145–74.72 µg/mL) in CAI4 and FR strains. FR strain showed resistance up to more than 125 µg/mL. (B) Pictorial representation of the CFU assay for CAI4 and FR strains under different conditions—control (YNB media only), fluconazole (125 µg/mL), sublethal deferasirox (DFX; 2.33 µg/ml), and fluconazole (125 µg/mL) + sublethal DFX (2.33 µg/mL). Graphical representation showed the percentage viability of CAI4 and FR strains relative to their control. The results of four independent biological repeats are represented as means ± SEM.
Fig 1 FR strain is more sensitive to iron chelation that can synergize with fluconazole-treatment to overcome resistance. (A) In vitro susceptibility study to fluconazole (0.24–125 µg/mL) and DFX (0.145–74.72 µg/mL) in CAI4 and FR strains. FR strain showed resistance up to more than 125 µg/mL. (B) Pictorial representation of the CFU assay for CAI4 and FR strains under different conditions—control (YNB media only), fluconazole (125 µg/mL), sublethal deferasirox (DFX; 2.33 µg/ml), and fluconazole (125 µg/mL) + sublethal DFX (2.33 µg/mL). Graphical representation showed the percentage viability of CAI4 and FR strains relative to their control. The results of four independent biological repeats are represented as means ± SEM.CC BY · PubMed Central
Fig 2 FR strain shows high intracellular iron levels supported by induction of iron-uptake genes. (A) CAI4 and FR strains were exposed to high-iron and low-iron conditions and intracellular iron level was measured by calorimetric assay. Results of three biological repeats with triplicates are represented as mean ± SEM. Statistical significance analysis was assessed by one-way ANOVA, *P < 0.05, ****P < 0.0001. (B) Expression study of iron uptake and iron utilization related genes in CAI4 and FR strains by real-time PCR analysis. 18s rRNA gene was used to measure the relative fold expression of genes. The results of four independent biological repeats with triplicates are represented as means ± SEM. Statistical significance analysis was assessed by one-way ANOVA.
Fig 2 FR strain shows high intracellular iron levels supported by induction of iron-uptake genes. (A) CAI4 and FR strains were exposed to high-iron and low-iron conditions and intracellular iron level was measured by calorimetric assay. Results of three biological repeats with triplicates are represented as mean ± SEM. Statistical significance analysis was assessed by one-way ANOVA, *P < 0.05, ****P < 0.0001. (B) Expression study of iron uptake and iron utilization related genes in CAI4 and FR strains by real-time PCR analysis. 18s rRNA gene was used to measure the relative fold expression of genes. The results of four independent biological repeats with triplicates are represented as means ± SEM. Statistical significance analysis was assessed by one-way ANOVA.CC BY · PubMed Central
Fig 3 Iron enhances ergosterol synthesis as well as influences β-glucan architecture in FR strain. (A) Percent ergosterol levels of CAI4 and FR strains were measured in high and low iron. The results of two independent biological repeats are represented as means ± SEM. (B) Gene expression study of ergosterol biosynthesis pathway-related genes was assessed in CAI4 and FR strains under high and low iron by real-time PCR analysis. 18s rRNA gene was used to measure expression of genes. The results of four independent biological repeats with triplicates are represented as means ± SEM. (C) β-glucan level and (D) β-glucan exposure were measured by aniline blue dye and anti-β-1,3-glucan antibody in high iron and low iron, respectively. Mean fluorescence intensities (MFIs) for n > 150 cells from three independent biological experiments are represented as mean ± SEM. (E) Efflux study in CAI4 and FR strains was performed in high and low iron conditions. 2% glucose was added after 30 min of R6G incubation to a glucose-free PBS. The experiment was repeated two times. The graphs show the results of one representative experiment. Statistical significance analysis was assessed by one-way ANOVA, *P < 0.05, **P < 0.01.
Fig 3 Iron enhances ergosterol synthesis as well as influences β-glucan architecture in FR strain. (A) Percent ergosterol levels of CAI4 and FR strains were measured in high and low iron. The results of two independent biological repeats are represented as means ± SEM. (B) Gene expression study of ergosterol biosynthesis pathway-related genes was assessed in CAI4 and FR strains under high and low iron by real-time PCR analysis. 18s rRNA gene was used to measure expression of genes. The results of four independent biological repeats with triplicates are represented as means ± SEM. (C) β-glucan level and (D) β-glucan exposure were measured by aniline blue dye and anti-β-1,3-glucan antibody in high iron and low iron, respectively. Mean fluorescence intensities (MFIs) for n > 150 cells from three independent biological experiments are represented as mean ± SEM. (E) Efflux study in CAI4 and FR strains was performed in high and low iron conditions. 2% glucose was added after 30 min of R6G incubation to a glucose-free PBS. The experiment was repeated two times. The graphs show the results of one representative experiment. Statistical significance analysis was assessed by one-way ANOVA, *P < 0.05, **P < 0.01.CC BY · PubMed Central
Fig 4 Low-iron mice reduce FR strain fungal burden in murine OPC model. (A) Pictorial representation of high-iron and low-iron murine OPC model infected with FR strain followed by treatment with fluconazole (FLC) 1 mg/kg/day. (B) CFU/gram of tongue tissue was obtained from C. albicans-infected mice. The data were pooled from mice (n = 10) and represented as mean ± SEM by Box-and-Whisker plot. Statistical analysis was performed by Mann-Whitney test, *P < 0.05.
Fig 4 Low-iron mice reduce FR strain fungal burden in murine OPC model. (A) Pictorial representation of high-iron and low-iron murine OPC model infected with FR strain followed by treatment with fluconazole (FLC) 1 mg/kg/day. (B) CFU/gram of tongue tissue was obtained from C. albicans-infected mice. The data were pooled from mice (n = 10) and represented as mean ± SEM by Box-and-Whisker plot. Statistical analysis was performed by Mann-Whitney test, *P < 0.05.CC BY · PubMed Central
Fig 5 Synergistic killing of FR clinical strains of C. albicans by fluconazole and DFX. (Left) Synergistic effect of fluconazole and iron chelator DFX was studied in C. albicans FR clinical strains and CAI4 by CFU study. Control (YNB media only), fluconazole (125 µg/mL), sublethal deferasirox (DFX; 2.33 µg/mL), and fluconazole (125 µg/mL) + sublethal DFX (2.33 µg/mL) were used. (Right) Percentage reduction of growth was measured relative to their control CFU. The results of two independent biological repeats are represented as means ± SEM.
Fig 5 Synergistic killing of FR clinical strains of C. albicans by fluconazole and DFX. (Left) Synergistic effect of fluconazole and iron chelator DFX was studied in C. albicans FR clinical strains and CAI4 by CFU study. Control (YNB media only), fluconazole (125 µg/mL), sublethal deferasirox (DFX; 2.33 µg/mL), and fluconazole (125 µg/mL) + sublethal DFX (2.33 µg/mL) were used. (Right) Percentage reduction of growth was measured relative to their control CFU. The results of two independent biological repeats are represented as means ± SEM.CC BY · PubMed Central

Verification

Claims the paper makes

11 Valid · 0 Not valid · 4 Not checked · 33 Own results and interpretations

19 more claims

Create a free account to see all 48 claims and every source verdict.

See all claims — free account
  • Probably not a substantial claim. 14
  • It may state two separate claims as one. 13
  • The quote only partly states this claim. 1

Create a free account to see these claims.

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

3 of 3

Citations

Cites

Show all 39 references

Cited by

See all 8

Metadata

Authors
Sharma, R., Nahar, A., & Puri, S.
Affiliations
Temple University (US)
Corresponding author
Puri, Sumant
Venue
Infection and Immunity
Published
2025-03-11
Volume
93
Issue
3
Pages
e0000225-e0000225
ISSN
  • 0019-9567 (ISSN-L)
  • 1098-5522
OpenAlex
W4407239752
Cited by
8
References
39
Citations by year
2026: 4 · 2025: 4
FWCI
6.10
Type
journal article
Language
en
Open access
Licence
Locations
  • Infection and Immunity (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
HHS | NIH | National Institute of Dental and Craniofacial Research (R01DE030130)
Topics
  • Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Fungal and yeast genetics research
  • Life Sciences › Agricultural and Biological Sciences › Plant Science › Fungal Plant Pathogen Control
Keywords
Candida albicans, fluconazole resistance, iron absorption, deferasirox, iron chelation, ergosterol biosynthesis, ERG11, drug synergy, antifungal resistance, fungal virulence, β-glucan, mouse infection model
MeSH terms
Deferasirox, Animals, Antifungal Agents, Candida albicans, Candidiasis, Ergosterol, Iron, Microbial Sensitivity Tests, Fluconazole, Drug Resistance, Fungal, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Candida albicans enhances iron uptake to maintain fluconazole resistance. https://app.cochat.ai/papers/10.1128/iai.00002-25
The paper
Sharma, R., Nahar, A., & Puri, S. (2025). Candida albicans enhances iron uptake to maintain fluconazole resistance. Infection and Immunity. https://doi.org/10.1128/iai.00002-25

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.